【スタッフ紹介】堀田 勝幸

【専門領域】
呼吸器悪性腫瘍、新薬開発

【所属学会】
日本内科学会、日本臨床腫瘍学会、他

【略歴】
大学卒業後、呼吸器内科領域・腫瘍内科領域の診療や研究に従事
現在、岡山大学病院 新医療研究開発センター臨床研究部所属

【一言】
がんを含めた臨床研究の院内外の推進・支援を行っています

【主な業績】
2015年分
原著論文

  1. Hotta K (Corresponding author), Sasaki J, Saeki S, Takigawa N, Katsui K, Takayama K, Nogami N, Shioyama Y, Bessho A, Kishimoto j, Tanimoto M, Kiura K. Gefitinib Combined with Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: the LOGIK0902/OLCSG0905 Intergroup Study Protocol. Clin Lung Cancer 2016 Jan;17(1):75-9.
  2. Ninomiya K, Hotta K (Corresponding author), Hisamoto-Sato A, Ichihara E, Gotoda H, Morichika D, Tamura T, Kayatani H, Minami D, Kubo T, Tabata M, Tanimoto M, Kiura K. Short-term Low-volume Hydration in Cisplatin-based Chemotherapy for Patients with Lung Cancer: The Second Prospective Feasibility Study in the Okayama Lung Cancer Study Group Trial 1201.Int J Clin Oncol 2016 Feb;21(1):81-7.
  3. Kudo K, Hotta K (Corresponding author), Ichihara E, Yoshioka H, Kunimasa K, Tsubouchi K, Iwasaku M, Kato Y, Oze I, Takigawa N, Tanimoto M, Kiura K. Impact of body surface area on survival in EGFR-mutant non-small cell lung cancer patients treated with gefitinib monotherapy: observational study of the Okayama Lung Cancer Study Group 0703. Cancer Chemother Pharmacol 2015 Aug;76(2):251-6.
  4. Hotta K (Corresponding author), Kato Y, Leighl N, Takigawa N, Gaafar RM, Kayatani H, Hirata T, Ohashi K, Kubo T, Tabata M, Tanimoto M, Kiura K. Magnitude of the benefit of progression-free survival as a potential surrogate marker in phase 3 trials assessing targeted agents in molecularly selected patients with advanced non-small cell lung cancer: Systematic Review. Plos One 2015;10:e0121211.
  5. Nogami N, Takigawa N, Hotta K (Corresponding author), Segawa Y, Kato Y, Kozuki T, Oze I, Kishino D, Aoe K, Ueoka H, Kuyama S, Harita S, Okada T, Hosowaka S, Inoue K, Gemba K, Shibayama T, Tabata M, Takemoto M, Kanazawa S, Tanimoto M, Kiura K. A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501. Lung Cancer. 2015;87:141-7.

戻る

コメントは受け付けていません。